• Latest Posts

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma

Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease

Llama Antibodies Could Be the Key to Universal Flu Prevention

A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains


Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug

Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III

Belgian Pharma’s Single-Tablet HIV Treatment Approved in the EU

Update: After 25 years, MorphoSys Gets its First Antibody Approved

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

More News! 9 Feb 2017

After its First Success, the Virtual Biotech Team is Back at it Again